JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

JNJ

230.16

+0.93%↑

UNH

371.5

+0.84%↑

TMO

476.61

+2.17%↑

ISRG

455.46

+0.87%↑

ABT

90.47

-1.62%↓

McKesson Corp

Отворен

СекторЗдравеопазване

806.08 -2.75

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

787.32

Максимум

833.47

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

23.926

67.147

Дивидентна доходност

0.37

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+15.52% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.37%

2.36%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.07.2026 г.

Следваща дата на екс-дивидент

1.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-3.8B

101B

Предишно отваряне

808.83

Предишно затваряне

806.08

Настроения в новините

By Acuity

26%

74%

99 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.04.2026 г., 23:53 ч. UTC

Печалби

Naver Posts Weaker First-Quarter Earnings

29.04.2026 г., 23:41 ч. UTC

Горещи акции

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29.04.2026 г., 23:55 ч. UTC

Печалби

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29.04.2026 г., 23:54 ч. UTC

Печалби

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29.04.2026 г., 23:52 ч. UTC

Печалби

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Печалби

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29.04.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan 1Q Net CNY1.70B, Down 14%

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan: Power Generation Down 2.9% as of End-March

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss Narrows>000002.SZ

29.04.2026 г., 23:18 ч. UTC

Печалби

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29.04.2026 г., 23:17 ч. UTC

Печалби

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29.04.2026 г., 23:13 ч. UTC

Печалби

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29.04.2026 г., 23:12 ч. UTC

Печалби

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29.04.2026 г., 23:04 ч. UTC

Печалби

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29.04.2026 г., 23:04 ч. UTC

Печалби

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

15.52% нагоре

12-месечна прогноза

Среден 964.56 USD  15.52%

Висок 1,107 USD

Нисък 828 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

99 / 348 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat